Double-Blind Trial of Miglitol in Type 2 Diabetic Patients With Insulin Treatment

Sanwa Kagaku Kenkyusho

Status and phase: Completed; Phase 3

Conditions: Type 2 Diabetes Mellitus

Treatments: Drug: Miglitol

Study type: Interventional

Funder types: Industry

Identifiers

NCT00213070

MG1005

Details and patient eligibility

About

The purpose of this study is evaluate the clinical efficacy and safety of Miglitol in patients with Type2 Diabetes Mellitus with treated insulin.

Sex: All

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Type2 diabetes
• Criteria of postprandial plasma glucose and HbA1c are met

Exclusion criteria

• Type1 diabetes
• Patients with antidiabetic drugs
• The other exclusion criteria are met

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind